glp 1 stocks How GLP-1 medications are transforming diabetes and weight loss treatment Lilly's GLP-1 Surge Dwarfs Abbott's

After their success in the obesity field, GLP-1 agonists are gaining interest in addiction treatment

The most common designs are observational studies

How much is Ozempic in Mexico

Eli Lilly have a new, once-monthly GLP1/GIP agonist (Brenipatide) and they're running some fascinating trials with it Smoking cessation, bipolar disorder, schizophrenia, opioid use disorder, depression, alcohol use disorder, and asthma

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

These results suggest chronic treatment with GLP-1R agonists could lead to proliferation/chronic activation of PSCs, which may lead to important effects in the pancreas.